The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page; Joanne E. McKenzie; Patrick M. Bossuyt; Isabelle Boutron; Tammy C. Hoffmann; Cynthia D. Mulrow; Larissa Shamseer; Jennifer M. Tetzlaff; Elie A. Akl; Sue E. Brennan; Roger Chou; Julie Glanville; Jeremy M. Grimshaw; Asbjørn Hróbjartsson; Manoj M. Lalu; Tianjing Li; Elizabeth W. Loder; Evan Mayo-Wilson; Steve McDonald; Luke A. McGuinness; Lesley A. Stewart; James Thomas; Andrea C. Tricco; Vivian A. Welch; Penny Whiting; David Moher

doi:https://doi.org/10.1136/bmj.n71

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt, Isabelle Boutron, Tammy C. Hoffmann, Cynthia D. Mulrow, Larissa Shamseer, Jennifer M. Tetzlaff, Elie A. Akl, Sue E. Brennan, Roger Chou, Julie Glanville, Jeremy M. Grimshaw, Asbjørn Hróbjartsson, Manoj M. Lalu, Tianjing Li, Elizabeth W. Loder, Evan Mayo-Wilson, Steve McDonald, Luke A. McGuinnessLesley A. Stewart, James Thomas, Andrea C. Tricco, Vivian A. Welch, Penny Whiting, David Moher

Research output: Contribution to journal › Review article › Academic › peer-review

28065 Citations (Scopus)

Abstract

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.

Original language	English
Article number	n71
Journal	BMJ (Clinical research ed.)
Volume	372
DOIs	https://doi.org/10.1136/bmj.n71
Publication status	Published - 29 Mar 2021

Access to Document

https://doi.org/10.1136/bmj.n71

Cite this

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ (Clinical research ed.), 372, Article n71. https://doi.org/10.1136/bmj.n71

@article{fbaa69e42b43425a9758906b5f60bde3,

title = "The PRISMA 2020 statement: An updated guideline for reporting systematic reviews",

abstract = "The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.",

author = "Page, {Matthew J.} and McKenzie, {Joanne E.} and Bossuyt, {Patrick M.} and Isabelle Boutron and Hoffmann, {Tammy C.} and Mulrow, {Cynthia D.} and Larissa Shamseer and Tetzlaff, {Jennifer M.} and Akl, {Elie A.} and Brennan, {Sue E.} and Roger Chou and Julie Glanville and Grimshaw, {Jeremy M.} and Asbj{\o}rn Hr{\'o}bjartsson and Lalu, {Manoj M.} and Tianjing Li and Loder, {Elizabeth W.} and Evan Mayo-Wilson and Steve McDonald and McGuinness, {Luke A.} and Stewart, {Lesley A.} and James Thomas and Tricco, {Andrea C.} and Welch, {Vivian A.} and Penny Whiting and David Moher",

note = "Publisher Copyright: {\textcopyright}",

year = "2021",

month = mar,

day = "29",

doi = "https://doi.org/10.1136/bmj.n71",

language = "English",

volume = "372",

journal = "BMJ (Clinical research ed.)",

issn = "0959-8146",

publisher = "British Medical Association",

}

Page, MJ, McKenzie, JE, Bossuyt, PM, Boutron, I, Hoffmann, TC, Mulrow, CD, Shamseer, L, Tetzlaff, JM, Akl, EA, Brennan, SE, Chou, R, Glanville, J, Grimshaw, JM, Hróbjartsson, A, Lalu, MM, Li, T, Loder, EW, Mayo-Wilson, E, McDonald, S, McGuinness, LA, Stewart, LA, Thomas, J, Tricco, AC, Welch, VA, Whiting, P & Moher, D 2021, 'The PRISMA 2020 statement: An updated guideline for reporting systematic reviews', BMJ (Clinical research ed.), vol. 372, n71. https://doi.org/10.1136/bmj.n71

TY - JOUR

T1 - The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

AU - Page, Matthew J.

AU - McKenzie, Joanne E.

AU - Bossuyt, Patrick M.

AU - Boutron, Isabelle

AU - Hoffmann, Tammy C.

AU - Mulrow, Cynthia D.

AU - Shamseer, Larissa

AU - Tetzlaff, Jennifer M.

AU - Akl, Elie A.

AU - Brennan, Sue E.

AU - Chou, Roger

AU - Glanville, Julie

AU - Grimshaw, Jeremy M.

AU - Hróbjartsson, Asbjørn

AU - Lalu, Manoj M.

AU - Li, Tianjing

AU - Loder, Elizabeth W.

AU - Mayo-Wilson, Evan

AU - McDonald, Steve

AU - McGuinness, Luke A.

AU - Stewart, Lesley A.

AU - Thomas, James

AU - Tricco, Andrea C.

AU - Welch, Vivian A.

AU - Whiting, Penny

AU - Moher, David

PY - 2021/3/29

Y1 - 2021/3/29

N2 - The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.

AB - The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.

UR - http://www.scopus.com/inward/record.url?scp=85103451714&partnerID=8YFLogxK

U2 - https://doi.org/10.1136/bmj.n71

DO - https://doi.org/10.1136/bmj.n71

M3 - Review article

C2 - 33782057

SN - 0959-8146

VL - 372

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

M1 - n71

ER -

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Abstract

Access to Document

Other files and links

Cite this